Research · head to head
Form Bio vs STARLIMS
Form Bio
Research
Computational platform for cell and gene therapy design and manufacturability
- From
- On request
- Rated
- -
STARLIMS
Research
Laboratory information management from Abbott for regulated and public health labs
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Form Bio the company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.; STARLIMS implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
- They diverge on capability: Form Bio covers FormManufacturing, STARLIMS covers Sample and specimen management.
- Prices and features above were last checked on 31 August 2026.
Where they differ
Only the attributes on which Form Bio and STARLIMS actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Form Bio
- FormManufacturing
- Payload design optimisation
- Genome integrity analysis
- Manufacturability prediction
- In silico workflows
- Scale-up monitoring
- Cell and gene therapy focus
- Collaboration
Only in STARLIMS
- Sample and specimen management
- Quality management
- Instrument integration
- Public health reporting
- Regulatory compliance
- Web and mobile access
What people use each for
The jobs each tool is most often brought in to do.
Form Bio
- A gene therapy developer discovering manufacturability problems with an AAV construct late in process development and wanting to move that analysis earliernot STARLIMS
- A biotech comparing several candidate payload designs in silico before committing to expensive production runsnot STARLIMS
- A CDMO characterising what a client construct actually produces against what was specifiednot STARLIMS
- A programme team needing genome integrity evidence to support regulatory conversations about product consistencynot STARLIMS
STARLIMS
- Public health laboratories handling surveillance and outbreak investigationnot Form Bio
- Clinical laboratories needing regulated specimen tracking and reportingnot Form Bio
- Food safety and environmental testing laboratoriesnot Form Bio
- Multi-site laboratory networks standardising methods and specificationsnot Form Bio
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Form Bio
- The company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
- The current offering launched AAV-focused, so developers working in lentiviral, mRNA or cell therapy modalities are outside the scope the platform was built and validated for.
- No pricing is published and engagements are scoped per programme, which makes it impossible to size the commitment before entering a sales process.
- This is a young venture-funded company whose analyses feed regulatory-facing decisions, so continuity of the vendor over a multi-year development programme is a genuine diligence question rather than a formality.
- Predictive manufacturability models need real production data to be trustworthy, and the value depends on how much of that a young vendor has accumulated, which is difficult for a buyer to verify independently.
STARLIMS
- Implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
- Pricing is quote-based with no public reference, making early budget setting difficult
- The breadth across laboratory types means some verticals get less development attention than others
- Interface modernisation has lagged behind newer cloud-native laboratory platforms
- Over-specified for small laboratories, where a lighter LIMS delivers most of the value for a fraction of the effort
Pricing, plan by plan
Form Bio
On request- FormManufacturing$undefined/year
- Pricing only through a sales process
- Scoped per therapeutic programme rather than per seat
- AAV-focused offering at launch
STARLIMS
On request- STARLIMS$undefined/year
- Sample management
- Quality management
- Instrument integration
Which should you pick?
Choose Form Bio if
- You need formmanufacturing.
- You work on Web, Cloud.
- You also want payload design optimisation.
Choose STARLIMS if
- You need sample and specimen management.
- You work on Web, Windows, Cloud, On-premise.
- You also want quality management.
Questions people ask
- Is Form Bio or STARLIMS better?
- Neither clearly leads. Form Bio starts at On request and STARLIMS at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Form Bio or STARLIMS?
- Form Bio starts at On request and STARLIMS at On request.
- Does Form Bio or STARLIMS run on more platforms?
- Form Bio runs on Web, Cloud. STARLIMS runs on Web, Windows, Cloud, On-premise.
- What is Form Bio best used for?
- Form Bio is most often used for a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier, a biotech comparing several candidate payload designs in silico before committing to expensive production runs, a cdmo characterising what a client construct actually produces against what was specified, a programme team needing genome integrity evidence to support regulatory conversations about product consistency. Of those, a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier and a biotech comparing several candidate payload designs in silico before committing to expensive production runs are not what STARLIMS is typically brought in for.
- What can Form Bio do that STARLIMS cannot?
- Form Bio covers FormManufacturing, Payload design optimisation, Genome integrity analysis, Manufacturability prediction. STARLIMS covers Sample and specimen management, Quality management, Instrument integration, Public health reporting.
Answered from the vendors’ own pages
Form Bio: What does Form Bio sell now?
FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.
STARLIMS: Who owns STARLIMS?
Abbott. That gives it institutional weight in laboratory procurement and a natural relationship with Abbott diagnostic instruments.
Form Bio: Is it still a general bioinformatics platform?
No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.
STARLIMS: Where is it strongest?
Public health and clinical laboratories. Surveillance reporting, outbreak investigation and unpredictable specimen surges are different problems from pharmaceutical QC, and it handles them well.
Form Bio: Where did the company come from?
It spun out of Colossal Biosciences in 2022.
STARLIMS: What does it cost?
Not published. Enterprise licensing plus implementation, quoted on laboratory count, users and modules.
Form Bio: Is pricing published?
No. Engagements are scoped per programme through a sales process.
STARLIMS: How does it compare to LabWare?
Both are enterprise LIMS with regulatory depth. LabWare is more dominant in pharmaceutical QC; STARLIMS has more presence in public health and clinical. Implementation partner quality matters more than the platform difference.
STARLIMS: What decides a successful implementation?
Configuration and validation quality, not platform features. Evaluations that compare feature lists rather than implementation approach are asking the wrong question.
Related pages
Other head to heads
- Form Bio vs Benchling
- Form Bio vs DNAnexus
- Form Bio vs Dotmatics
- Form Bio vs Seven Bridges
- Form Bio vs Terra
- Form Bio vs OpenEye, Cadence Molecular Sciences
- Form Bio vs Schrodinger
- Form Bio vs Sapio Sciences
- Form Bio vs Mouseflow
- Form Bio vs Chemaxon
- Form Bio vs Labguru
- Form Bio vs Obsidian
- Form Bio vs Paperpile
- Form Bio vs Reduct
- Form Bio vs Remesh
- Form Bio vs Scispot
- Form Bio vs LabWare
- Form Bio vs Thermo SampleManager LIMS
- Form Bio vs LabVantage
- Form Bio vs Medidata Rave
- Form Bio vs Roam Research
- Form Bio vs Contentsquare
- Form Bio vs Castor EDC
- Form Bio vs Suzy
- Form Bio vs TetraScience
- Form Bio vs Valispace
- Form Bio vs Wolfram Mathematica
- STARLIMS vs Benchling
- STARLIMS vs DNAnexus
- STARLIMS vs Dotmatics
- STARLIMS vs Seven Bridges
- STARLIMS vs Terra
- STARLIMS vs OpenEye, Cadence Molecular Sciences
- STARLIMS vs Schrodinger
- STARLIMS vs Sapio Sciences
- STARLIMS vs Mouseflow
- STARLIMS vs Chemaxon
- STARLIMS vs Labguru
- STARLIMS vs Obsidian
- STARLIMS vs Paperpile
- STARLIMS vs Reduct
- STARLIMS vs Remesh
- STARLIMS vs Scispot
- STARLIMS vs LabWare
- STARLIMS vs Thermo SampleManager LIMS
- STARLIMS vs LabVantage
- STARLIMS vs Medidata Rave
- STARLIMS vs Roam Research
- STARLIMS vs Contentsquare
- STARLIMS vs Castor EDC
- STARLIMS vs Suzy
- STARLIMS vs TetraScience
- STARLIMS vs Valispace
- STARLIMS vs Wolfram Mathematica